Event
Date: March 24, 2020
Location: Regenstrief Institute, 1101 W. 10th St., Indianapolis, IN 46202

2020 LOINC Conference – Indianapolis

LOINC 2020 Indy Meeting

In-person workshops for March 25 have been cancelled for this event. Committee meetings on March 24 and 26 will be online only.

Join LOINCers from around the globe at this special event featuring informative presentations and—for the first time in the U.S.—both the Laboratory LOINC Committee and Clinical LOINC Committee meetings.

This event will be held at LOINC’s home, Regenstrief Institute in Indiana. Our beautiful facility is the ideal location for three days of learning, collaboration, and networking.

DAY 1: MARCH 24 – Laboratory Committee Meeting
The Laboratory LOINC Committee convenes on the first day of the conference to hear updates on LOINC adoption and discuss key issues for development and implementation. All are welcome! You may attend as part of the conference or separately at no cost. Remote attendance is also available.

DAY 2: MARCH 25 – Educational Workshops & Presentations
We’re excited to offer a range of hands-on training sessions, with each one led by top LOINCers and implementers. Review the entire schedule and find the options that best fits your needs. During registration, you will select the sessions you plan to attend.

DAY 3: MARCH 26 – Clinical Committee Meeting
The Clinical LOINC Committee will meet on the final day of the conference. Hear updates and issues related to the clinical domain. All committee meetings are open to the public and free. Remote attendance is available for this event as well.

Registration deadline is March 19!

LEARN MORE & REGISTER

Related News

Kurt Kroenke, MD

The Impact of Patient Race, Patient Socioeconomic Status, and Cognitive Load of Physician Residents and Fellows on Chronic Pain Care Decisions

Published in the Journal of Pain. Here is a link to the article.  Regenstrief Institute authors:  Kurt Kroenke, PhD 

Shaun Grannis and Brian Dixon

Latest booster reduces adults’ risk of moderate or severe COVID by more than half

The most recent COVID-19 booster shot reduces adults’ risk of moderate or severe COVID by more than half, according

April Savoy, PhD

Closing the referral loop: perspectives and experiences of primary care and specialist physicians

INDIANAPOLIS – Every year, millions of referrals are made by primary care physicians in the U.S. for patients needing